Expression of -gal epitopes on ovarian carcinoma membranes to be used as a novel autologous tumor vaccine

Author： Galili U.   Chen Z.-c.   DeGeest K.  

Publisher： Elsevier

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.90, Iss.1, 2003-07, pp. : 100-108

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Autologous tumor vaccines processed to express α-gal epitopes: a practical approach to immunotherapy in cancer

By Galili Uri  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 11, 2004-11 ,pp. : 935-945

Springer Publishing Company

Access to resources Recommend Favorite

Pancreatic cancer immunotherapy using a tumor lysate vaccine, engineered to express α-gal epitopes, targets pancreatic cancer stem cells

By  

International Journal of Oncology, Vol. 46, Iss. 1, 2015-01 ,pp. : 78-90

Spandidos Publications

Access to resources Recommend Favorite

Quality of life in patients with metastatic renal cell carcinoma participating in a phase I trial of an autologous tumor-derived vaccine

By Cohen L.   de Moor C.   Parker P.A.   Amato R.J.  

Urologic Oncology: Seminars and Original Investigations, Vol. 7, Iss. 3, 2002-05 ,pp. : 119-124

Elsevier

Access to resources Recommend Favorite

Interleukin15: A potent adjuvant enhancing the efficacy of an autologous wholecell tumor vaccine against Lewis lung carcinoma

By              

Molecular Medicine Reports, Vol. 10, Iss. 4, 2014-01 ,pp. : 1828-1834

Spandidos Publications

Access to resources Recommend Favorite

Notch1 expression correlates with tumor differentiation status in ovarian carcinoma

By Wang Mingyi  

Medical Oncology, Vol. 27, Iss. 4, 2010-12 ,pp. : 1329-1335

Humana Press, Inc

Access to resources Recommend Favorite